Genetics and Gene Expression Involving Stress and Distress Pathways in Fibromyalgia with and without Comorbid Chronic Fatigue Syndrome.
Light, Kathleen C, White, Andrea T, Tadler, Scott et al. · Pain research and treatment · 2012 · DOI
Quick Summary
This study looked at genes and how they are expressed (turned on or off) in people with fibromyalgia and chronic fatigue syndrome. Researchers focused on three main biological systems: the stress response system, the hormone system that controls stress, and the serotonin system (which affects mood and pain). They found that certain genes, particularly those controlling stress hormones and pain sensing, may play a role in why some people develop or maintain these conditions.
Why It Matters
Understanding the genetic and molecular basis of ME/CFS could help explain why objective biological dysfunction occurs despite reliance on subjective symptom criteria for diagnosis. Identifying specific dysregulated pathways may eventually lead to targeted treatments and improve recognition of the disease's physiological nature. This work supports the concept that ME/CFS involves measurable biological abnormalities, not just psychological factors.
Observed Findings
Dysregulation in catechol-O-methyl transferase (COMT) gene variants associated with stress hormone metabolism
Altered expression of glucocorticoid and mineralocorticoid receptors (NR3C1, NR3C2) in stress response pathways
Abnormalities in P2X4 purinergic ion channels involved in pain sensation and microglia activation
Evidence of both resting and stressor-evoked changes in leukocyte gene expression in affected populations
Potential overlap in genetic pathways between fibromyalgia with and without comorbid CFS
Inferred Conclusions
Inherited genetic susceptibility and/or physiological dysregulation contribute to FMS and CFS development and maintenance across multiple stress-response systems
The adrenergic, HPA axis, and serotonergic pathways represent key biological mechanisms underlying these disorders' symptomatology
P2X4 ion channel dysfunction may mechanistically link abnormal pain/fatigue sensing to central nervous system inflammation
Genetic and gene expression profiling can provide objective biomarkers complementary to subjective symptom-based diagnosis
Remaining Questions
How do COMT, NR3C1/NR3C2, and P2X4 variants specifically contribute to disease onset versus disease maintenance, and are there gene-environment interactions?
What This Study Does Not Prove
This review does not prove that any single gene causes ME/CFS or fibromyalgia; rather, it identifies associations suggesting genetic contributions to susceptibility. The study cannot establish causation from correlations or distinguish between primary genetic effects and secondary gene expression changes resulting from chronic illness. It also does not account for how medications (particularly antidepressants) or comorbid depression may influence the observed gene expression patterns.